LeterMovir
(1)
Letermovir (917389-32-3) El uso de Letermovir en el tratamiento de enfermedades del corazón
Precio: Negotiable
MOQ: Negotiable
El tiempo de entrega: Negotiable
Destacar:Letermovir 917389-32-3, 99% Lletermovir prophylaxis, CAS: 917389-32-3 Letermovir API
Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems. Product Name: Letermovir CAS No.: 917389-32-3 Assay: 99% Specification: CP, EP, In-house, a... Ver más
➤ Visitar Sitio web